Blood cancers, Myeloma
Results
Other
This study looked at how often people being treated with lenalidomide and dexamethasone for myeloma have a very low number of white blood cells (neutropenia).
Recruitment start: 17 January 2011
Recruitment end: 5 July 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Williams
Amgen
Last reviewed: 26 Jan 2018
CRUK internal database number: 8194
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
